Jubilant Pharma names Gurpartap Singh Sachdeva as CEO

Jubilant Life Sciences has appointed Gurpartap Singh Sachdeva as CEO of Jubilant Pharma, a wholly-owned subsidiary of the pharmaceutical company.

Singh will be based in the United States and have the overall responsibility for the operations under Jubilant Pharma. He will report to the Jubilant Pharma Board, the company said in a release.

Prior to Jubilant, Singh had served as president of Sun Pharmaceuticals, US.

He has worked extensively both in India and in the US in various leadership roles pertaining to Strategy, Mergers and Acquisitions, Commercial and Operations.

Jubilant Life Sciences is engaged in manufacture and supply of APIs, generics, speciality pharmaceuticals and life science ingredients.